74. <strong>Andriole</strong>, G.L.: Technical Changes in Contemporary Radical Retropubic Prostatectomy. Canadian J Urology 3(1):66-68, 1996. 75. Nadler, R.B. and <strong>Andriole</strong>, G.L.: Who is Best Benefitted by Radical Prostatectomy. Hematology/Oncology Clinics of North America. 10:(3) 581-503, 1996. 76. Klutke, C.G, Tiemann, D.D., Nadler, R.B., and <strong>Andriole</strong>, G.L. : Antegrade Collagen Injection for Stress Incontinence after Radical Prostatectomy: Technique and Early Results. J. Endourology 10(3):279-282, 1996. 77. Keetch D.W. and <strong>Andriole</strong>, G.L.: Prostate Cancer Screening: What are Physicians to do? What have we learned? 1996 Monographs in Urology. 17(3)29-48, 1996. 78. Keetch, D.W., McMurtry, J.M., Smith, D.S., <strong>Andriole</strong>, G.L. and Catalona, W.J.: PSA Density vs. PSA Slope as Predictors of Prostate Cancer in Men with Initially Negative Prostatic Biopsies. J. Urology 156:428-431, 1996. 79. Klutke, C.G., Nadler, R.B. and <strong>Andriole</strong>, G.L.: Early Results with Antegrade Collagen Injection for Post Radical Prostatectomy Stress Urinary Incontinence. J. Urology 156:1703-1706, 1996. 80. Monk, T.G., Goodnough, L.T., Pulley, D.D., Folger, W., Martin, K.J., Colberg, J.W., and <strong>Andriole</strong>, G.L.: Safety of Acute Normovolemic Hemodilution in Elderly Patients. Anesthesiology 85(No. 3A)A33, 1996. 81. <strong>Andriole</strong>, G.L.: Watchful Waiting Versus Early Intervention: Are There Guidelines for Prostate Cancer Today? Advances in Oncology 12(4):8-13, 1996. 82. Ornstein, D.K., Rao, G.S., Johnson, B., Charlton, E.T. and <strong>Andriole</strong>, G.L.: Combined Finasteride and Flutamide Therapy in Men with Advanced Prostate Cancer. Urology 48:901-905, 1996. 83. Colberg, J.W., <strong>Andriole</strong>, G.L., and Catalona, W.J.: Long Term Follow-up of Men Undergoing Modified Inguinal Lymphadenectomy for Carcinoma of the Penis. Br. J. Urology 79:54-57, 1997. 84. Ornstein, D.K., Arcangeli, C.G. and <strong>Andriole</strong>, G.L.: Renal Masses: Urologic Management. MRI Clinics of North American 5(1)1-12, 1997. 85. Ornstein, D.K., Rao, G.S., Smith, D.S. and <strong>Andriole</strong>, G.L.: Impact on Systematic Ultrasound-Guided Prostate Biopsy on Prostate Cancer Incidence in Men Undergoing Transurethral Resection of the Prostate. J Urology 157:880-884, 1997. 86. Arcangeli, C.G., Ornstein, D.K., Keetch, D.W., and <strong>Andriole</strong>, G.L.: PSA as a Screening Test for Prostate Cancer: The United States Experience. Urologic Clinics of North America. 24(2):299-306, 1997. 87. Wolf, J.S. and <strong>Andriole</strong>, G.L.: The Selection of Patients for Cross-Sectional Imaging and Pelvic Lymphadenectomy Before Radical Prostatectomy. AUA Update 16:114-119, 1997. 88. Goodnough, L.T., Monk, T.G., and <strong>Andriole</strong>, G.L.: Erythropoietin Therapy. NEJM 336:933-938, 1997. 89. <strong>Andriole</strong>, G.L.: Adjuvant Therapy for Prostate Cancer Patients at High Risk of Recurrence following Radical Prostatectomy. European Urology. 32(3):65-69, 1997. 26
90. Monk, T.G., Goodnough, L.T., Brecher, M.E., Pulley, D.D., Colberg, J.W., <strong>Andriole</strong>, G.L., and Catalona, W.J.: Acute Normovolemic Hemodilution Can Replace Preoperative Autologous Blood Donation as a Standard of Care for Autologous Blood Procurement in Radical Prostatectomy. Anesth Analg, 85:953-958, 1997. 91. Keetch, D.W., <strong>Andriole</strong>, G.L., Ratliff, T.L., and Catalona, W.J.: Comparison of Percentage-Free Prostate Specific Antigen Levels in Men with Benign Prostatic Hyperplasia Treated with Finasteride, Terazosin, or Watchful Waiting. Urology 50:901-905, 1997. 92. McConnell JD, Bruskewitz R, Walsh PC, <strong>Andriole</strong>, GL, et al: The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. New Engl J Med 338(9):557-563, 1998. 93. <strong>Andriole</strong>, G.L., Guess, H.A., Epstein, J.I., Wise H., Kadmon, D., Crawford, E.D., Hudson, P., Jackson, C.L., Romas, N.A., Patterson, L., Cook, T.J., Waldstreicher, J., and the PLESS Study Group: Treatment with Finasteride Preserves Usefulness of Prostate-Specific Antigen in the Detection of Prostate Cancer: Results of a Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Urology 52:195-202, 1998. 94. Ornstein, D.K., Oh, J., Herschman, JD and <strong>Andriole</strong>, G.L.: Evaluation and Management of the Man who has Failed Primary Curative Therapy of Prostate Cancer. Urologic Clinics of North America 25(4):591- 601, 1998. 95. Ornstein, D.K., Smith, D.S., and <strong>Andriole</strong>, G.L.: Biochemical Response to Testicular Androgen Ablation Among Advanced Prostate Cancer Patients Failing Flutamide and Finasteride Therapy. Urology 52(6):1094-1097, 1998. 96. Ornstein D.K., Beiser, J.A., and <strong>Andriole</strong>, G.L.: Anaemia in Men Receiving Combined Finasteride and Flutamide Therapy for Advanced Prostate Cancer. British Journal of Urology 83:43-46, 1998. 97. Roehrborn, CG, McConnell JD, Lieber M, et al: Serum Prostate-Specific Antigen Concentration is a Powerful Predictor of Acute Urinary Retention and Need for Surgery in Men with Clinical Benign Prostatic Hyperplasia. Urology 53:473-480, 1999. 98. Alexander F.E., <strong>Andriole</strong>, G.L., Aus G., et al: Rationale for Randomized Trials of Prostate Cancer Screening. European Journal of Cancer, 35(2):262-271, 1999. 99. <strong>Andriole</strong>, G.L.: Editorial Comment: The Controversy About Androgen Deprivation Therapy for Prostate Cancer. Infections in Urology 12(3):73, 1999. 100. Niemczyk, P., Klutke, C.G., and <strong>Andriole</strong>, G.L.: Technical Aspects of Umbilical Appendicovesicostomy. Contemporary Urology: Surgeon’s Corner 11(8): 76-87, 1999. 101. Klutke, J.J., Chhikara, S., <strong>Andriole</strong>, G.L., and Klutke, C.G.: Long-Term Results After Antegrade Collagen Injection for Stress Urinary Incontinence Following Radical Retropubic Prostatectomy. Urology 53:974-977, 1999. 102. Hudson, P.B., Boake, R., Trachtenberg, J., Romas, N.A., Rosenblatt, S., Narayan P., Geller, J., Lieber, M.M., Elhilali, M., Rittmaster, R., Cox, C.E., Perreault, J.P., Malek, G.H., Bruskewitz, R.C., Roy, J.B., Ko, A., Jacobsen C.A., Stoner, E., and the North American Finasteride Study Group: Efficacy of Finasteride is Maintained in Patients with Benign Prostatic Hyperplasia Treated for 5 Years. Urology 53(4):690-695, 1999. 27
- Page 1 and 2: CURRICULUM VITAE Gerald Louis Andri
- Page 3 and 4: Chairman, Steering Committee, REDUC
- Page 5 and 6: Period: 2002-2009 Grant Title: Comp
- Page 7 and 8: Grant Title: A Double-Blind, Random
- Page 9 and 10: implant) in Community-Based Patient
- Page 11 and 12: BIBLIOGRAPHY: I. ABSTRACTS 1. Andri
- Page 13 and 14: 27. Andriole, G.L., Coplen, D.E., a
- Page 15 and 16: 52. Andriole, G.L., Rao, G.S., Kawa
- Page 17 and 18: 76. Yan, Y., Andriole, G.L., Diaz,
- Page 19 and 20: 99. Albala, D.M., Andriole, G.L., D
- Page 21 and 22: 123. Grubb RL III, Black A, Church
- Page 23 and 24: 28. Clayman, R.V., McClennan, B.W.,
- Page 25: 60. Keetch, D.W., Andriole, G.L., C
- Page 29 and 30: Thermotherapy (P-TUMT) for the Trea
- Page 31 and 32: 144. Andriole, G.L., Bostwick, D.,
- Page 33 and 34: 170. Marks, L.S., Roehrborn, C.G. a
- Page 35 and 36: D.S., Chanock, S.J., Thun, M.J. and
- Page 37 and 38: 14. Andriole, G.L.: Tumor markers i